EICHORCondition: Migraine · Sponsor: Zogenix, Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * History of 2 to 6 migraine headaches per month * Migraines should have been present for at least 1 year with age at onset of migraine less than 50 years * History of 24 hours of freedom between migraine attacks * Current users of triptan medications * Able to distinguish interval or other non-migrainous headaches from typical migraine * General good health Exclusion Criteria: * History or symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes * Significant underlying cardiovascular diseases including uncontrolled hypertension * Hemiplegic or basilar migraine * History or diagnosis of severe hepatic or renal impairment * History of epilepsy or seizure or other serious neurologic condition * History of allergy, anaphylaxis, or hypersensitivity to sumatriptan or any of its components or similar drugs including sulphonamides * History of scleroderma (systemic sclerosis) * Pregnant or breastfeeding * Use of contraindicated prescription medications, monoamine oxidase inhibitors (MAO-A), selective serotonin reuptake inhibitors, or lithium agents
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| University of Alabama Hospital, Dept. of Neurology | Birmingham, Alabama, United States | — |
| Arizona Research Center | Phoenix, Arizona, United States | — |
| C. Phillip O'Carroll, MD, Inc | Newport Beach, California, United States | — |
| California Medical Clinic for Headache | Santa Monica, California, United States | — |
| Alpine Clinical Research | Boulder, Colorado, United States | — |
| University Clinical Research Inc. | Pembroke Pines, Florida, United States | — |
| Comprehensive Neuroscience Inc | St. Petersburg, Florida, United States | — |
| Comprehensive Neurosciences Inc | Atlanta, Georgia, United States | — |
| Neurology Specialists of Decatur | Decatur, Georgia, United States | — |
| Diamond Headache Clinic | Chicago, Illinois, United States | — |
| Michigan Head, Pain, & Neurological Institute | Ann Arbor, Michigan, United States | — |
| Clinvest/A Division of Banyan Group, Inc | Springfield, Missouri, United States | — |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01016834